Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LAP3 | P28838 | 1/20 | 0.31 |
| ▸ | METAP1 | P53582 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21087633 | 0.85 | — | — | |
| SCHEMBL17375881 | 0.83 | LAP3 (0.33) | LAP3METAP1MMP1MMP2MMP3 | |
| SCHEMBL18596920 | 0.82 | FDPS (0.35) | LAP3METAP1MMP1MMP2MMP3 | |
| SCHEMBL12643184 | 0.80 | FDPS (0.34) | LAP3METAP1MMP1MMP2MMP3 | |
| SCHEMBL11688376 | 0.80 | LAP3 (0.35) | LAP3METAP1MMP1MMP2MMP3 | |
| SCHEMBL21096102 | 0.79 | CTSA (0.39) | — | |
| SCHEMBL10935251 | 0.78 | LAP3 (0.32) | LAP3METAP1MMP1MMP2MMP3 | |
| SCHEMBL15128196 | 0.76 | FDPS (0.34) | LAP3METAP1MMP1MMP2MMP3 | |
| SCHEMBL4958007 | 0.74 | LAP3 (0.30) | LAP3 | |
| SCHEMBL12240712 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11370863-B2 | Oral care compositions comprising phosphono-phosphate and anionic group containing polymers | THE PROCTER & GAMBLE COMPANY (US) | 2022-06-28 | — | — | US | disclosed |
| US-11046817-B2 | Compositions comprising multi-valent cations and phosphono-phosphate containing polymers | THE PROCTER & GAMBLE COMPANY (US) | 2021-06-29 | — | — | US | disclosed |
| US-20210047475-A1 | ORAL CARE COMPOSITIONS COMPRISING PHOSPHONO-PHOSPHATE AND ANIONIC GROUP CONTAINING POLYMERS | PROCTER & GAMBLE (US) | 2021-02-18 | — | — | US | disclosed |
| US-20190177489-A1 | Compositions Comprising Multi-valent Cations and Phosphono-phosphate Containing Polymers | THE PROCTER & GAMBLE COMPANY | 2019-06-13 | — | — | US | disclosed |
| US-20190177490-A1 | ORAL CARE COMPOSITIONS COMPRISING PHOSPHONO-PHOSPHATE AND ANIONIC GROUP CONTAINING POLYMERS | THE PROCTER & GAMBLE COMPANY | 2019-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210047475-A1 | ORAL CARE COMPOSITIONS COMPRISING PHOSPHONO-PHOSPHATE AND ANIONIC GROUP CONTAINING POLYMERS | PHOSPHO1, PHPT1, INPP5D | LAP3 2648/4885METAP1 1963/4885MMP1 2946/4885 |
| US-11370863-B2 | Oral care compositions comprising phosphono-phosphate and anionic group containing polymers | PHOSPHO1, PHPT1, INPP5D | LAP3 2648/4885METAP1 1963/4885MMP1 2946/4885 |
| US-11046817-B2 | Compositions comprising multi-valent cations and phosphono-phosphate containing polymers | PHOSPHO1, INPP5D, PTEN | LAP3 1977/4885METAP1 2117/4885MMP1 4468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.